Showing results (111-120 of 260) with videos related to
Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II studyHeinz Ludwig, Zdenek Adam, Roman Hajek, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 7, 2025
Uncoupling Metastasis and Epithelial-to-Mesenchymal Transition in sgP19/kRAS-Driven Spontaneous Metastatic Liver Tumor ModelJingwen Wang, Zijing Xu, Lei Xu, et al.Human Pathology|January 18, 2011
Gastrointestinal stromal tumor presenting as a rectovaginal mass. Clinicopathologic and molecular-genetic characterization of a rare tumor with a literature reviewAntje-Friederike Pelz, Abbas Agaimy, Marc Daniels, et al.International Journal of Molecular Sciences|February 11, 2023
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular CarcinomaSara M Steinmann, Anabel Sánchez-Martín, Elisabeth Tanzer, et al.Cell Death & Disease|February 6, 2020
Oncogene-dependent function of BRG1 in hepatocarcinogenesisPan Wang, Xinhua Song, Dan Cao, et al.Wiener Klinische Wochenschrift|February 21, 2006
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicityNina Worel, Axel Schulenburg, Margit Mitterbauer, et al.Transfusion|July 19, 2003
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantationNina Worel, Peter Kalhs, Felix Keil, et al.European Journal of Haematology|December 16, 2019
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomasSandro M Wagner, Thomas Melchardt, Alexander Egle, et al.Journal of Hypertension|October 3, 2014
Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorptionOlaf Grisk, Anna Koenen, Thomas Meissner, et al.International Journal of Molecular Sciences|September 27, 2016
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsSilvia Ribback, Verena Sailer, Enrico Böhning, et al.Pageof 26